BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3547852)

  • 1. Preclinical evaluation of immunosuppression selective for T cells recognizing class I histocompatibility antigens.
    Wright JK; Barrett LV; Delmonico FL; Fuller TC; Cosimi AB
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1106-9. PubMed ID: 3547852
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of cellular events within stable and rejecting allografts in cynomolgus monkeys.
    Wee SL; Colvin RB; Stroka DM; Jolliffe LK; Cosimi AB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):821-3. PubMed ID: 1990702
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunobiology of transplant rejection.
    Häyry P
    Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479
    [No Abstract]   [Full Text] [Related]  

  • 5. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Bedle M; Colvin RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):501-3. PubMed ID: 1990600
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of pretransplant immune parameters with the rapidity of onset of acute rejection and renal allograft survival time.
    Shabtai M; Waltzer WC; Pullis CK; Raisbeck A; Shabtai E; Malinowski K; Rapaport FT
    Transplant Proc; 1990 Aug; 22(4):1917-9. PubMed ID: 2389485
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
    Reed MH; Shapiro ME; Strom TB; Carpenter CB; Letvin NL; Reimann K; Weinberg DS; Waldmann TA; Kirkman RL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1028-30. PubMed ID: 2650064
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model.
    Hayes JM; Spencer W; Valenzuela R; Caulfield M; Novick AC
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1006-9. PubMed ID: 2650061
    [No Abstract]   [Full Text] [Related]  

  • 9. Does cyclosporine improve the results of HLA-identical renal transplantation?
    Flechner SM; Kerman RH; Van Buren CT; Lorber MI; Barker CJ; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1485-8. PubMed ID: 3547866
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of human renal allograft and experimental prolongation of renal graft survival].
    Hirano T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):389-92. PubMed ID: 6386637
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cyclosporine immunosuppression in humans.
    Kerman RH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):143-52. PubMed ID: 3284064
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary nonfunction and preformed anti-HLA antibodies.
    Vaidya S; Orchard P; Haneke R; Fish J
    Transplant Proc; 1995 Feb; 27(1):1033-5. PubMed ID: 7878791
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal effect of cyclosporine immunosuppression on T lymphocyte subsets, Ia-reactive cells, and donor-specific immunity in cardiac allograft recipients.
    Mazaheri R; Stiller CR; Keown P; McKenzie N; Howson W; Farrow K; McFarlane D; Sinclair NR
    Transplant Proc; 1984 Dec; 16(6):1537-9. PubMed ID: 6390861
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies.
    Thomas FT; Griesedieck C; Thomas J; Carver M; Whitley T; Warren R; Williams D
    Transplant Proc; 1984 Dec; 16(6):1561-3. PubMed ID: 6239426
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic effects of cyclosporine.
    Wish JB
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):15-8. PubMed ID: 3487144
    [No Abstract]   [Full Text] [Related]  

  • 16. New approaches to the use of antibodies for immunosuppression.
    Russell PS
    Transplant Proc; 1982 Sep; 14(3):506-8. PubMed ID: 6758236
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative cyclosporine: interaction with multifactorial variables and effect on allograft function.
    Mendez R; Koussa N; Alanizi A; Mendez RG; Iwaki Y; Bogaard TP; Khetan U
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):12-5. PubMed ID: 3515677
    [No Abstract]   [Full Text] [Related]  

  • 19. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.